1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 23 MARCH 2015

Cancer Drug News 23 MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Lilly Can Use Local Biotech To Grow Presence In China
Industry Brief - NKTR-102 Prolongs Median OS In Phase III BC Study
Industry Trend Analysis - Imbruvica Will Allow AbbVie To Recoup After Costly Pharmacyclics Deal
Industry Trend Analysis - EC Approval For PV Pushes Jakavi Closer To Blockbuster Status
Industry Brief - Vaxil's ImMucin Gains EU Orphan Drug Designation For MM
Industry Brief - BioInvent To Conduct Phase IIa Study In MM Post ASCT
Industry Brief - Coronado/NeuPharma To Co-Develop Covalent Third-Generation EGFr Inhibitors
Industry Brief - Tokai/QIAGEN Expand Deal To Develop AR-V7 Companion Diagnostic
Industry Brief - Lonsurf Combination Tablet Approved In Japan For Partial Change In Indications
Industry Brief - BioInvent To Initiate TB-403 Phase I/IIa Programme In Medulloblastoma
Industry Brief - Nova Secures Funds To Develop Liquid Formulation Of 13-CRA
Industry Brief - Opdivo Approved In South Korea For Melanoma
Industry Brief - Myriad And BioMarin Expand Companion Diagnostic Collaboration
Industry Brief - Celldex/Roche Enter Clinical Trial Collaboration For Varlilumab/MPDL3280A
Industry Brief - Vaccinex/Five Prime Sign Multi-Target Ab Discovery Deal
Industry Trend Analysis - Teva Deal Highlights Ignyta's Strong Future In Oncology Market
Industry Trend Analysis - Genmab Bolsters Pipeline With iDD Antibody Deal
Industry Trend Analysis - AstraZeneca Preparing Well To Stave Off Potential Further Takeover Bids
Industry Brief - Aeglea Raises Funds To Develop Treatments For Inborn Errors Of Metabolism
Industry Brief - Kite Strengthens TCR Product Platform With T-Cell Factory Acquisition

Table Of Contents

Cancer Drug News 23 MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in Tanzania

  • December 2016
    9 pages
  • Anti-Infective  

  • Tanzania  

    Africa  

View report >

Opioid Market in Iran

  • December 2016
    8 pages
  • Opioid  

  • Iran  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.